Activest Wealth Management
DFTX icon

Activest Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Activest Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.51K Hold
66
– – ﹤0.01% 778
2026
Q2 		$3.1K Hold
66
– – ﹤0.01% 788
2026
Q1 		$1.25K Hold
66
– – ﹤0.01% 1004
2025
Q4 		$884 Hold
66
– – ﹤0.01% 956
2025
Q3 		$778 Hold
66
– – ﹤0.01% 906
2025
Q2 		$428 Hold
66
– – ﹤0.01% 885
2025
Q1 		$386 Hold
66
– – ﹤0.01% 874
2024
Q4 		$459 Hold
66
– – ﹤0.01% 541
2024
Q3 		$376 Hold
66
– – ﹤0.01% 499
2024
Q2 		$476 Buy
+66
New +$577 ﹤0.01% 461
2021
Q4 		– Sell
-3
Closed -$1K – 372
2021
Q3 		$1K Buy
+3
New +$130 ﹤0.01% 353

Other funds holding DFTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Patient Square Capital
Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Activest Wealth Management's DFTX Position: Q3 2026 in Review

Activest Wealth Management held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 66 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Activest Wealth Management first reported a position in DFTX in Q3 2021 and has held it in 11 quarters since. The position peaked at $3.1K in Q2 2026. 159 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Activest Wealth Management held 66 shares of Definium Therapeutics worth $2.51K as of Q3 2026.
  • Activest Wealth Management left its Definium Therapeutics share count unchanged in Q3 2026.
  • Definium Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #778 holding.
  • Activest Wealth Management first reported a position in Definium Therapeutics in Q3 2021 and has held it in 11 quarters since.
  • Activest Wealth Management's Definium Therapeutics position peaked at $3.1K in Q2 2026.
  • 159 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.